Summary
In an attempt to transmit feline malignant lymphoma to mice, a murine hepatitis virus (MHV) was accidentally recovered from conventionally reared Swiss mice receiving prolonged treatment with antilymphocyte serum. In these mice, the virus did not require concomitant infection withEperythrozoon coccoides to produce disease. Tests for antibodies against a variety of viruses were performed on serum from control colony mice and mice that recovered from experimental infection as well as on serum pooled from vaccinated and non-vaccinated mice challenged with the recovered agent. Antibodies to the MHV complement fixing (CF) antigen(s) were demonstrated in only the last mentioned serum. Mice harbouring a hepatitis virus may thus be tolerant to their CF antigen(s) in a situation analogous to oncornavirus infection of their natural hosts. The liver pathology was that of a confluent focal-type necrosis resembling that produced by certain other MHV strains. We have labelled this newly isolated virus MHV (Swiss-Cape Town), abbreviated to MHV (S-CT).
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Allison, A. C.: Effects of antilymphocytic serum on bacterial and viral infections and virus oncogenesis. Fed. Proc.29, 167–168 (1970).
Bradburn, A. F., andD. A. J. Tyrrell: Coronaviruses of Man. Progr. med. Virol.13, 373–403 (1971).
Burnet, F. M.: Cellular Immunology, 1st Ed., pp. 539–543. Melbourne and Cambridge: Melbourne Univ. Press and the Syndics of the Cambridge University Press, 1969.
Evans, D. B., P. R. Millar, andB. M. Herbertson: Hepatic dysfunction associated with renal transplantation. Lancet2, 929–933 (1968).
Gerber, M. A., A. Brodin, D. Steinberg, S. Veruace, C. Yang, andF. Paronetto: Periarteritis nodosa, Australia antigen and lymphatic leukemia. New Engl. J. Med.286, 14–17 (1972).
Gerber, M., F. Schaffner, andF. Paronetto: Immuno-electron microscopy of hepatitis B antigen in liver. Proc. Soc. exp. Biol. (N.Y.)140, 1334–1339 (1972).
Gledhill, A. W.: Viral diseases in laboratory animals. In: The Problems of Laboratory Animal Disease, 1st Ed., p. 106. London and New York: Academic Press, 1962.
Gledhill, A. W., G. W. A. Dick, andC. H. Andrewes: Production of hepatitis in mice by the combined action of two filterable agents. Lancet2, 509–511 (1952).
Gledhill, A. W., G. W. A. Dick, andJ. S. F. Niven: Mouse hepatitis virus and its pathogenic action. J. Path. Bact.69, 299–309 (1955).
Huang, S., I. Millman, A. O'Connell, A. Aronoff, H. Gault, andB. S. Blumberg: Virus-like particles in Australia antigen associated hepatitis. Amer. J. Path.67, 453–462 (1972).
Huang, S. N., I. Millman, A. P. O'Connell, B. S. Blumberg, A. Aronoff, andH. Gault: Electronmicroscopic and immunoelectronmicroscopic studies of virus particles in human liver with Australia antigen associated hepatitis. Gastroenterology62, 161 (1972).
Heubner, R. J., andG. Todaro: Oncogenes of RNA tumor viruses as determinants of cancer. Proc. nat. Acad. Sci. (Wash.)64, 1087–1094 (1969).
Levey, R. H., andP. B. Medawar: Some experiments on the action of antilymphoid antisera. Ann. N.Y. Acad. Sci.129, 164–177 (1966).
Nelson, J. B.: Acute hepatitis associated with mouse leukemia. IV. The relationship ofEperythrozoon coccoides to the hepatitis virus of Princeton mice. J. exp. Med.98, 441–449 (1953).
Nelson, J. B.: An ascites tumor appearing during the passage ofEperythrozoon coccoides in mice. J. Exp. Med.103, 743–752 (1956).
Piazza, M.: Experimental Viral Hepatitis, 1st Ed. Springfield: Charles C. Thomas, 1969.
Rafyi, A., etP. H. Vercammen-Grandjean: Sur la morphologie et la transmission d'Eperythrozoon coccoides. Ann. Inst. Pasteur106, 938–942 (1964).
Schilling, V.:Eperythrozoon coccoides. Eine neue durch Splenekotmie aktivierbare Dauerinfektion der weißen Maus. Klin. Wschr.7, 1853–1855 (1928).
Weigle, W. O.: The immune response of rabbits tolerant to injections of BSA to the injection of other serum albumins. J. exp. Med.114, 111–125 (1961).
Weigle, W. O.: Termination of acquired immunological tolerance to protein antigens following immunization with altered protein antigens. J. exp. Med.116, 913–928 (1962).
Woodruff, M. F. A.: In: Antilymphocyte Serum (Ciba Foundation Study Group No. 29, London, 1967), pp. 108–109. London: J. and A. Churchill Ltd., 1967.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van der Riet, F.d.S.J., Kahn, L.B. Isolation of a murine hepatitis virus from Swiss mice treated with antilymphocyte serum. Archiv f Virusforschung 42, 1–8 (1973). https://doi.org/10.1007/BF01250502
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01250502